Your browser does not support JavaScript!

FranceBiotechnologies

FranceBiotechnologies est une plateforme pour découvrir les actualités, entreprises, produits et savoir-faire techniques de la biotechnologies. Partagez et échangez entre spécialistes.

Rejoignez la communauté
Une actualité de FierceBiotech a été ajouté(e)
Il y a 2 jours

Roche R&D executive begins a new voyage with biotech move

Il y a 3 jours
Another day, another Big Pharma executive jumping ship to biotech. On Tuesday morning, it was Omar Khwaja, M.D., Ph.D., who became chief medical officer at gene therapy specialist Voyager...
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 2 jours

Next Stop: Heidelberg! ????????

Il y a 4 jours
Heidelberg get ready! Leading national or international scientific institutions, world-renowned hospitals,research-intensive and innovative enterprises, you can find it all in Heidelberg. Therefore,...
labiotech.eu
Une actualité de L'Usine Nouvelle a été ajouté(e)
Il y a 2 jours

[Brexit] Quel impact sur les marques de l’UE?

Il y a 3 jours
Le 30 mars 2019, le Brexit sera effectif et le Royaume-Uni sera un pays tiers à l’Union européenne. 1) Quel impact en cas d’accord de retrait ?... - Cabinet Dechert
www.usinenouvelle.com
Une actualité de FierceBiotech a été ajouté(e)
Il y a 2 jours

Seres elevates CFO Eric Shaff to CEO post as it advances immunology therapies

Il y a 3 jours
Seres Therapeutics is promoting its chief operating and financial officer, Eric Shaff, to succeed Roger Pomerantz as its new president and CEO....
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Il y a 2 jours

Aimmune says shutdown blocks peanut allergy drug review

Il y a 3 jours
Aimmune Therapeutics has confirmed that the government shutdown will delay the FDA’s review of AR101, its oral immunotherapy for peanut allergy....
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 2 jours

Huntington’s Could Be Diagnosed in Five Minutes With This Lab-on-a-Chip

Il y a 3 jours
Using a lab-on-a-chip device, Swiss scientists have found a way to diagnose the neurodegenerative condition Huntington’s disease from DNA in the blood in just five minutes, rather than the five hours...
labiotech.eu
Une actualité de FierceBiotech a été ajouté(e)
Il y a 2 jours

Attendees fed up with venue, high prices call to move JPM out of San Francisco

Il y a 3 jours
While the high cost of living in San Francisco has famously grabbed headlines, the costs of simply meeting there, even for a few days, are becoming untenable for some....
www.fiercebiotech.com
SANOFI AVENTIS
est cité dans une actualité de Labiotech.eu
Il y a 2 jours

Sanofi Obtains License for French Company’s Antibody Engineering Platform

Il y a 3 jours
Sanofi has signed a licensing deal with French biotech Biomunex, whose antibody technology has the potential to develop new immunotherapy treatments for cancer and infectious diseases. Sanofi will...
labiotech.eu
Une actualité de FierceBiotech a été ajouté(e)
Il y a 2 jours

As Brexit nears, EMA improves staff retention forecast, commits to uninterrupted drug evaluations

Il y a 3 jours
The EMA has increased its forecast of the proportion of staff that will relocate with it to Amsterdam. Buoyed by the improved outlook, the agency has predicted its core drug evaluation activities will...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Il y a 3 jours

Verona tanks after COPD drug misses phase 2 endpoint

Il y a 4 jours
A phase 2 trial of Verona Pharma’s ensifentrine has missed its primary endpoint. The dual PDE3/PDE4 inhibitor failed to beat placebo on a measure of lung function, wiping more than 30% off Verona’s...
www.fiercebiotech.com
Charger plus d'actualités